Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Arestin"”.
-
Influence of Scaling and Root Planing with Minocycline Microspheres on Clinical Outcomes of Patients with Periodontitis
… derivative, is commercially marketed as Arestin®, offering substantivity. It remains active in periodontal pockets for 7–10 days and continues to release the drug for up to 14 days. With its dual mechanism of action—antibacterial effects and the ability to reduce tissue …
-
Influence of Scaling and Root Planing with Minocycline Microspheres on Clinical Outcomes of Patients with Periodontitis
… in a powder form, clinically marketed as “Arestin*”. With its property of substantivity (remains active in the periodontal pocket upto 7-10 days and releases minocycline till 14 days) and dual mode of action(bactericidal and minimize tissue destruction), it seems to be clinically effective …
-
Surgical Factors Related to Peri-Implant Diseases
… and 2023 who were pre-screened as a part of the Arestin study IRB (#815821) and later approved for this study. Data was extracted from clinical notes, radiographs, and periodontal records, with 96 variables assessed per implant using Microsoft Excel. Three researchers conducted a …
-
Adjunctive Therapy of Periodontal Disease with Minocycline Microspheres in Dental School Settings: A Retrospective Chart Review.
… in test and control groups. Results: For the Arestin group, mean short-term PD reduction was 1.14 mm, and long-term PD reduction was 1.18 mm. BOP reduction for the test group was 10.6% in the short-term follow-up and - 4.24% for a long-term period. Results: Control group showed a PD reduction …